9:00 – 10:30
|
OPEN Workshop – Topical Anti-psoriatics in 2007
An interactive session reviewing and discussing:
- the characteristics / classification of psoriatic patients
- treatment classes/formulations and matching them with different patients and caregivers
- the characteristics of optimal topical therapy
- the data on / use of different topical therapies (tars, anthralin, Dovobet®)
- the factors affecting patient compliance
- the effect of compliance on disease management success
- the characteristics of various topicals in relation to these characteristics
|
Dr. Richard Thomas, Moderator
Speakers:
Dr. Lyn Guenther
Dr. Leon Kircik
Dr. Richard Thomas
|
| 9:00 - 9:05 |
Welcome, Agenda Review, Objectives |
Dr. Richard Thomas |
| 9:05 - 9:25 |
Best strategies to manage psoriasis with limited health care resources |
Dr. Richard Thomas |
| 9:25 - 9:50 |
Topical medications review |
Dr. Lyn Guenther |
| 9:50 - 10:15 |
Compliance/Adherence with topicals |
Dr. Leon Kircik |
| 10:15 - 10:25 |
Other / special / off-label topicals |
Dr. Richard Thomas |
| 10:25 - 10:30 |
Summary |
Dr. Richard Thomas |
| 2:00 – 3:30 |
OPEN Workshop – Imiquimod Synergies with Surgery
|
Dr. Mariusz Sapijaszko
Dr. Neil Bhatia
Dr. Lyn Guenther |
| 4:00 – 5:20 |
Plenary Session 1
Room: SDB Centre and Est, Le Centre Sheraton Montreal |
Dr. Jerry Tan, Chair |
| 4:00 - 4:20 |
The Safety and Efficacy of Efalizumab for Treatment of Hand and Foot Psoriasis |
Dr. Chuck Lynde |
| 4:20 - 4:40 |
Combination Treatment for Psoriasis |
Dr. Leon Kircik |
| 4:40 - 5:00 |
The Role of the Dermatologist in Identifying
and Treating the Early Stages of PsA |
Dr. Sergio Chimenti |
| 5:00 - 5:20 |
Panel and Questions |
|
|
|
|
9:30 – 11:00
|
OPEN Workshop – Infliximab in the Real World
|
Dr Robert Bissonnette, Chair |
| |
Long Term Experience with Inliximab in the Real World |
Dr. Sergio Chimenti |
| |
How to initiate infliximab treatment in a general dermatoloty practice |
Dr. Robert Bissonnette |
| |
Managing Moderate to Severe Psoriais: A case based Approach |
Dr. Richard Langley |
| 11:30 – 1:30 |
OPEN Workshop – Therapeutic Options in the Pediatric Psoriasis Population
Objectives
- Provide participants with an overview of disease prevalence and pathogenesis of pediatric psoriasis
- Evaluate current and future therapeutic options for the treatment of pediatric psoriasis
- Review available safety and efficacy data on the use of etanercept for the treatment of inflammatory diseases in pediatric population
- Review practical case studies of therapeutic options and treatment in the pediatric psoriasis population
|
Dr. Danielle Marcoux, Chair |
| 11:30 - 12:00 |
Part 1
- Introduction and Objectives
- Overview of pathogenesis, prevalence, and clinical aspects of pediatric onset psoriasis (pop)
|
Dr. Danielle Marcoux |
| 12:00 - 12:30 |
Part 2
- Overview of therapies currently available (now and future) for pediatric psoriasis
|
Dr. Richard Langley |
| 12:30 - 1:00 |
Part 3
- Highlight the latest clinical trial data for Enbrel in juvenile rheumatoid arthritis
- Future trials in pediatric psoriasis
- Case studies of pediatric psoriasis
|
Dr. Ian Landells |
| 1:00 - 1:05 |
Chair Summary |
Dr. Danielle Marcoux |
| 1:05 - 1:30 |
Audience Q&A |
|
| 4:30 – 5:45 |
Plenary Session 2 |
Dr. Jason Rivers, Chair |
| 4:30 - 5:00 |
Gene Environment Interactions in Atopic Eczema: Implications for Treatment |
Dr. Michael Cork |
| 5:00 - 5:15 |
Seborrheic Dermatitis Etiology & Treatment |
Dr. James R. Schwartz |
| 5:15 - 5:30 |
The Importance of Sun Protection and the Role of Physical Sunblocks |
Dr. Joël Claveau |
| 5:30 - 5:45 |
Panel and Questions |
|
| 5:45 - 8:00 |
Cocktail Reception - SDB Foyer, Le Centre Sheraton Montreal |
|
|
|
|
